IL16 and ovarian neoplasm: This study examined, for the first time, suitability of IL-16-targeted contrast agent, a newly developed ultrasound imaging agent, in improving the in vivo visualization of ovarian tumors in laying hens, a preclinical model of spontaneous OVCA.